Rocket


Overview
Financials
News + Filings
Key Docs
Ownership

 
 

Parnell Pharmaceuticals Holdings Ltd (PARN) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Jun-30-14Jun-30-13
Revenues19.013.28.47.59.5
            Revenue growth44.6%57.5% -20.9% 
Cost of goods sold41.633.625.324.115.9
Gross profit-22.6-20.5-17.0-16.6-6.4
            Gross margin-118.6%-155.4%-203.0%-220.1%-66.6%
Selling, general and administrative0.00.00.00.00.0
EBIT-22.6-20.5-17.0-16.6-6.4
            EBIT margin-118.6%-155.4%-203.0%-220.1%-66.6%
Pre-tax income0.0-13.7-11.4-14.4-4.2
Income taxes0.00.03.03.0-0.7
            Tax rate    16.2%
Net income0.00.00.00.00.0
            Net margin0.0%0.0%0.0%0.0%0.0%
 
Diluted EPS$0.00$0.00$0.00$0.00$0.00
Shares outstanding (diluted)15,809.313,283.710,867.07,960.77,518.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy